A single view of all the companies in the same space to infer if the stock is undervalued, overvalued or priced right. This would be one way to analyze a longer terms investment in a particular sector.
| Company | Market Cap | Income | Sales | P/E | P/B | Cash/Share | Dividend | Dividend Yield | Price To Cash Ratio | Debt to Equity Ratio | ROE | ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Retractable Technologies, Inc. | 127,400,000 | 55,800,000 | 188,400,000 | 2.15 | 1.19 | 1.17 | - | - | 3.00 | 0.02 | 69.70% | 32.00% |
| AngioDynamics, Inc. | 965,720,000 | -39,700,000 | 306,100,000 | 0.00 | 2.14 | 0.58 | - | - | 40.41 | 0.06 | -9.20% | -7.20% |
| AtriCure, Inc. | 2,860,000,000 | 50,200,000 | 274,300,000 | 55.70 | 5.55 | 2.46 | - | - | 24.02 | 0.15 | 11.50% | 7.60% |
| Atrion Corporation | 1,290,000,000 | 33,100,000 | 165,000,000 | 37.33 | 5.01 | 32.32 | 7.80 | 1.15% | 21.00 | 0.00 | 13.60% | 12.30% |
| Antares Pharma, Inc. | 944,090,000 | 46,300,000 | 184,000,000 | 20.98 | 5.40 | 0.40 | - | - | 14.07 | 0.11 | 32.20% | 20.50% |
| Baxter International Inc. | 39,440,000,000 | 1,280,000,000 | 12,780,000,000 | 28.83 | 4.01 | 5.46 | 1.12 | 1.54% | 13.36 | 1.95 | 14.80% | 5.60% |
| Becton, Dickinson and Company | 77,240,000,000 | 1,680,000,000 | 19,930,000,000 | 44.68 | 3.05 | 6.39 | 3.48 | 1.35% | 40.42 | 0.72 | 6.90% | 3.10% |
| Femasys Inc. | 18,540,000 | 0 | 1,200,000 | 0.00 | 0.66 | 2.14 | - | - | 0.75 | 0.04 | - | - |
| Glaukos Corporation | 2,800,000,000 | -49,600,000 | 294,000,000 | 0.00 | 4.41 | 8.14 | - | - | 6.77 | 0.00 | -8.40% | -4.70% |
| G Medical Innovations Holdings Ltd | 17,540,000 | -13,100,000 | 4,600,000 | 0.00 | 0.00 | 0.04 | - | - | 35.07 | 0.00 | 179.20% | -139.80% |
| Haemonetics Corporation | 3,040,000,000 | 22,600,000 | 953,200,000 | 128.17 | 3.92 | 4.36 | - | - | 12.84 | 1.06 | 3.20% | 1.20% |
| ICU Medical, Inc. | 5,610,000,000 | 103,100,000 | 1,320,000,000 | 46.12 | 2.88 | 22.12 | - | - | 9.89 | 0.00 | 6.60% | 5.70% |
| InfuSystem Holdings Inc. | 162,180,000 | 1,400,000 | 102,400,000 | 115.08 | 3.11 | 0.01 | - | - | 810.91 | 0.68 | 3.10% | 1.50% |
| iRhythm Technologies, Inc. | 4,430,000,000 | -101,400,000 | 322,800,000 | 0.00 | 13.89 | 7.12 | - | - | 18.52 | 0.08 | -34.00% | -21.30% |
| Repro Med Systems, Inc. | 138,790,000 | -4,600,000 | 23,500,000 | 0.00 | 3.42 | 0.52 | - | - | 5.49 | 0.01 | -12.30% | -11.00% |
| LeMaitre Vascular, Inc. | 1,080,000,000 | 26,900,000 | 154,400,000 | 36.47 | 3.94 | 2.97 | 0.50 | 1.09% | 15.43 | 0.00 | 12.40% | 10.00% |
| Merit Medical Systems, Inc. | 4,030,000,000 | 48,500,000 | 1,070,000,000 | 79.15 | 3.63 | 1.13 | - | - | 59.37 | 0.23 | 4.80% | 2.90% |
| Nephros, Inc. | 45,020,000 | -4,099,999 | 10,400,000 | 0.00 | 3.50 | 0.62 | - | - | 6.43 | 0.03 | -33.90% | -23.00% |
| NeuroMetrix, Inc. | 28,460,000 | -2,300,000 | 8,300,000 | 0.00 | 1.07 | 2.98 | - | - | 1.26 | 0.00 | -14.80% | -13.10% |
| NovoCure Limited | 9,340,000,000 | -58,400,000 | 535,000,000 | 0.00 | 21.10 | 8.37 | - | - | 9.96 | 1.37 | -14.70% | -5.30% |
| Nyxoah S.A. | 445,860,000 | 0 | 420,000 | 0.00 | 4.50 | 0.00 | - | - | 0.00 | 0.00 | - | - |
| OraSure Technologies, Inc. | 503,360,000 | -23,000,000 | 233,700,000 | 0.00 | 1.23 | 1.98 | - | - | 3.29 | 0.01 | -5.80% | -5.00% |
| Pro-Dex, Inc. | 61,930,000 | 4,800,000 | 41,300,000 | 12.07 | 2.52 | 1.59 | - | - | 9.53 | 0.55 | 23.10% | 11.60% |
| Pulse Biosciences, Inc. | 109,650,000 | -63,700,000 | 1,400,000 | 0.00 | 2.64 | 0.00 | - | - | 0.00 | 0.01 | -156.00% | -90.30% |
| ResMed Inc. | 35,600,000,000 | 522,000,000 | 3,440,000,000 | 63.65 | 10.48 | 1.23 | 1.68 | 0.74% | 183.05 | 0.22 | 17.70% | 11.10% |
| Teleflex Incorporated | 16,480,000,000 | 485,100,000 | 2,810,000,000 | 31.91 | 4.07 | 8.81 | 1.36 | 0.42% | 37.03 | 0.49 | 13.60% | 6.90% |
| Utah Medical Products, Inc. | 319,480,000 | 14,800,000 | 49,100,000 | 21.61 | 2.98 | 16.67 | 1.16 | 1.33% | 5.24 | 0.00 | 13.80% | 12.70% |